Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for
COVID-19, is a novel human betacoronavirus that is rapidly spreading worldwide. The …

Messenger RNA has now been used to vaccinate millions of people. However, the diversity
of pulmonary pathologies, including infections, genetic disorders, asthma and others, …

Cas13a has been used to target RNA viruses in cell culture, but efficacy has not been
demonstrated in animal models. In this study, we used messenger RNA (mRNA)-encoded Cas13a …

A rapid, portable, and cost-effective method to detect the infection of SARS-CoV-2 is
fundamental toward mitigating the current COVID-19 pandemic. Herein, a human angiotensin-…

Rapid and sensitive pathogen detection is important for prevention and control of disease.
Here, we report a label-free diagnostic platform that combines surface-enhanced Raman …

The novel coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is responsible for the recent global pandemic. The …

A rapid and cost-effective method to detect the infection of SARS-CoV-2 is fundamental to
mitigating the current COVID-19 pandemic. Herein, a surface-enhanced Raman spectroscopy (…

Effective vaccines are slowing the COVID-19 pandemic, but SARS-CoV-2 will likely remain
an issue in the future making it important to have therapeutics to treat patients. There are few …

RNA viruses like SARS-CoV-2, influenza virus, and respiratory syncytial virus (RSV) are
dependent on host genes for replication. We investigated if probenecid, an FDA-approved and …

Respiratory syncytial virus (RSV) infection can cause bronchiolitis, pneumonia, morbidity,
and some mortality, primarily in infants and the elderly, for which no vaccine is available. The …